"Amiodarone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
| Descriptor ID |
D000638
|
| MeSH Number(s) |
D03.633.100.127.075
|
| Concept/Terms |
Cordarone- Cordarone
- Amiodarex
- Trangorex
- Kordaron
- Cordarex
|
Below are MeSH descriptors whose meaning is more general than "Amiodarone".
Below are MeSH descriptors whose meaning is more specific than "Amiodarone".
This graph shows the total number of publications written about "Amiodarone" by people in this website by year, and whether "Amiodarone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amiodarone" by people in Profiles.
-
Mason JM, Krenz JR, Koehl JL, Fuh L, Nagurney JT, Wilcox SR, Hayes BD. Amiodarone versus digoxin for acute rate control of atrial fibrillation in the emergency department. Am J Emerg Med. 2022 12; 62:133-135.
-
Shannon K, Saltzman D, Li I, Mokszycki R, Galletta G. Ventricular tachycardia converts to sinus rhythm after administration of propofol. Am J Emerg Med. 2021 10; 48:377.e1-377.e3.
-
Bosch NA, Rucci JM, Massaro JM, Winter MR, Quinn EK, Chon KH, McManus DD, Walkey AJ. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation. Chest. 2021 04; 159(4):1452-1459.
-
Atreya AR, Priya A, Pack QR, Pekow PS, Stefan M, Lagu T, Lotfi AS, Lindenauer PK. Use and Outcomes Associated With Perioperative Amiodarone in Cardiac Surgery. J Am Heart Assoc. 2019 08 06; 8(15):e009892.
-
Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, Rastegar H, Estes NAM, Maron MS, Maron BJ. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy. Circulation. 2017 Dec 19; 136(25):2420-2436.
-
Walkey AJ, Evans SR, Winter MR, Benjamin EJ. Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study. Chest. 2016 Jan; 149(1):74-83.
-
Reynolds MR, Lin J, Jhaveri M, Mozaffari E, Plich A. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial. Am J Ther. 2014 Nov-Dec; 21(6):500-8.
-
Lam J, Gomes T, Juurlink DN, Mamdani MM, Pullenayegum EM, Kearon C, Spencer FA, Paterson M, Zheng H, Holbrook AM. Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone. Am J Cardiol. 2013 Aug 01; 112(3):420-3.
-
Goodman IS, Lu CJ. Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia. Pediatr Emerg Care. 2012 Jan; 28(1):47-8.
-
Essebag V, Reynolds MR, Hadjis T, Lemery R, Olshansky B, Buxton AE, Josephson ME, Zimetbaum P. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. 2007 Aug 13-27; 167(15):1648-53.